Integrated Cellular Resolution Framework for Blood-Lineage Identity, Functional State, Communication Biology, and Engineering Target Discovery
Program Code: HEMOREGEN-CHAR-002
Division: HEMOREGEN-BLD-100
Parent Program: HEMOREGEN-BLD-CHAR-001
Classification: Single-Cell Systems Biology Mapping Platform
Status: Strategic Development Blueprint v1.0
EXECUTIVE SUMMARY
Single-Cell Multi-Omic Mapping is the cellular-resolution discovery engine of PROJECT HEMOREGEN-721.
Its purpose is to characterize each blood and hematopoietic cell at the level of:
- Genomic identity
- Transcriptomic program
- Epigenetic state
- Surface proteomic phenotype
- Intracellular proteomic activity
- Metabolic condition
- EV communication output
- Regenerative potential
- Disease-associated drift
- Engineering suitability
This mapping program converts the blood system from a bulk-cell model into a high-resolution cellular intelligence atlas.
SECTION I — PROGRAM OBJECTIVE
Primary Objective
Generate a complete single-cell multi-omic map of human blood and hematopoietic compartments.
Strategic Outputs
Output | Purpose |
Cell Identity Map | Define all blood-cell populations |
Lineage State Map | Trace differentiation trajectories |
Functional State Map | Identify activation, exhaustion, tolerance, regeneration |
EV Communication Map | Link each cell state to EV output |
Failure Map | Identify disease-associated cellular drift |
Engineering Target Map | Prioritize therapeutic intervention points |
SECTION II — CELLULAR COMPARTMENTS TO MAP
Hematopoietic Stem and Progenitor Cells
- LT-HSC
- ST-HSC
- Multipotent progenitors
- Common myeloid progenitors
- Common lymphoid progenitors
- Megakaryocyte-erythroid progenitors
Mature Blood Cells
- Erythrocytes
- Reticulocytes
- Platelets
- Neutrophils
- Eosinophils
- Basophils
- Monocytes
- Dendritic cells
- T cells
- B cells
- NK cells
- Tregs
Bone Marrow Niche Cells
- Stromal cells
- Endothelial cells
- Osteolineage cells
- Mesenchymal stromal cells
- Macrophage niche cells
- Perivascular support cells
SECTION III — MULTI-OMIC DATA LAYERS
Omic Layer | Core Readout | HEMOREGEN Use |
scGenomics | Mutations, clonal architecture | Detect malignant or regenerative clones |
scTranscriptomics | RNA expression programs | Define cell state and lineage identity |
scEpigenomics | Chromatin accessibility, methylation | Map memory, plasticity, commitment |
scProteomics | Surface and intracellular proteins | Validate phenotype and signaling |
scMetabolomics | Energy and redox state | Assess functional capacity |
scEVomics | EV output, cargo, address code | Map communication behavior |
Spatial Omics | Tissue-localized cell behavior | Map marrow niche organization |
Functional Phenomics | Assay-based behavior | Validate biological activity |
SECTION IV — STANDARD SINGLE-CELL PROFILE SCHEMA
Each mapped cell receives a standardized HEMOREGEN Cellular Identity Record.
Field | Description |
Cell ID | Unique single-cell identifier |
Lineage | Hematopoietic origin |
Maturation Stage | Stem, progenitor, precursor, mature |
Functional State | Resting, activated, inflammatory, regenerative, exhausted |
Genomic Status | Variant or clonal features |
Transcriptomic Program | Active gene-expression modules |
Epigenetic State | Commitment and plasticity status |
Surface Phenotype | Protein marker identity |
Metabolic State | Glycolytic, oxidative, hypoxic, stressed |
EV Signature | EV production/cargo/address profile |
Engineering Class | Diagnostic, therapeutic, regenerative, synthetic-template |
SECTION V — FUNCTIONAL STATE CLASSIFICATION
State | Signature | Engineering Relevance |
Homeostatic | Stable baseline profile | Reference standard |
Activated | Cytokine and signaling induction | Immune engineering |
Inflammatory | NF-κB / interferon activation | Disease monitoring |
Tolerogenic | IL-10, TGFβ, FOXP3-linked patterns | Treg-EV platforms |
Cytotoxic | Granzyme, perforin, IFN-associated programs | NK/CTL-EV platforms |
Regenerative | Growth factor and repair signaling | Blood reconstruction |
Exhausted | PD-1, TOX, metabolic decline | Immune restoration |
Senescent | SASP-like signaling, low repair capacity | Aging biology |
Malignant Drift | Clonal expansion, lineage distortion | Early detection |
SECTION VI — LINEAGE TRAJECTORY MAPPING
Objective
Reconstruct how blood cells transition from stem-cell states to mature functional states.
Core Trajectories
Trajectory | Key Output |
HSC → Erythroid | Oxygen-delivery reconstruction targets |
HSC → Megakaryocyte | Platelet and hemostasis engineering targets |
HSC → Myeloid | Innate immune restoration targets |
HSC → Lymphoid | Adaptive immune rebuilding targets |
Progenitor → Malignant Clone | Leukemia-risk detection |
HSC → Exhausted/Senescent State | Aging and regenerative failure mapping |
SECTION VII — SINGLE-CELL EVOMIC MAPPING
Objective
Assign EV communication behavior to each blood-cell subtype and functional state.
EVomic Parameter | Definition |
EV Production Rate | Number and class of EVs released |
Cargo Profile | RNA, protein, lipid, metabolite cargo |
Address Code | Targeting and routing signature |
Functional Message | Immune, regenerative, metabolic, suppressive, cytotoxic |
Recipient Target | Expected receiving cell or organ |
Communication Fidelity | Accuracy and consistency of EV output |
Key EVomic Outputs
- APC-EV priming signatures
- Treg-EV tolerance signatures
- NK/CTL-EV cytotoxic signatures
- Platelet-EV repair signatures
- RBC-EV hypoxia signatures
- HSC/MSC-EV regenerative signatures
SECTION VIII — DISEASE DRIFT MAPPING
Disease-associated cellular drift is classified across five SCF fault layers.
Fault Layer | Single-Cell Manifestation |
Identity Drift | Loss of normal lineage markers |
Functional Drift | Abnormal activation or suppression |
Communication Drift | Distorted EV output |
Regenerative Drift | Reduced self-renewal or lineage bias |
Malignant Drift | Clonal expansion and transformation |
Priority Disease Contexts
- Bone marrow failure syndromes
- Leukemia and clonal hematopoiesis
- Autoimmune disease
- Chronic infection
- Cancer immune exhaustion
- Aging-associated immune decline
- Transfusion-related immune dysfunction
SECTION IX — ANALYTICAL WORKFLOW
Phase 1 — Sample Acquisition
Sources:
- Peripheral blood
- Bone marrow aspirate
- Mobilized stem-cell collections
- Disease-specific cohorts
- Healthy reference cohorts
Phase 2 — Cell Partitioning
Methods:
- Flow cytometry sorting
- Magnetic enrichment
- Droplet-based single-cell capture
- Plate-based single-cell capture
Phase 3 — Multi-Omic Profiling
Assays:
- scRNA-seq
- scATAC-seq
- CITE-seq
- Single-cell immune profiling
- Single-cell methylome analysis
- Spatial transcriptomics
- EV-linked profiling
Phase 4 — Data Integration
Outputs:
- Unified cell atlas
- Lineage trajectory maps
- Cell-state signatures
- Communication networks
- Engineering target rankings
SECTION X — COMPUTATIONAL ARCHITECTURE
Core Model
Single-cell data are integrated into the HEMOREGEN Blood Cell Graph.
Graph Element | Biological Equivalent |
Node | Single cell or cell state |
Edge | Lineage or communication relationship |
Weight | Transition probability or signaling strength |
Cluster | Cell population |
Trajectory | Differentiation pathway |
Overlay | Disease or therapeutic state |
Computational Modules
- Cell-type annotation engine
- Lineage trajectory engine
- Clonal architecture engine
- EV communication inference engine
- Disease-drift classifier
- Engineering target prioritizer
- Digital twin integration module
SECTION XI — ENGINEERING TARGET PRIORITIZATION
Target Classes
Class | Example Use |
Identity Targets | Stabilize lineage identity |
Regenerative Targets | Expand HSC and progenitor capacity |
Communication Targets | Correct EV signaling |
Immune Targets | Restore cytotoxicity or tolerance |
Metabolic Targets | Improve energy and redox function |
Synthetic Template Targets | Build artificial blood components |
Priority Engineering Outputs
- HSC expansion targets
- Treg-EV cargo optimization targets
- NK/CTL cytotoxic enhancement targets
- APC-EV vaccine potency targets
- Platelet synthetic engineering targets
- RBC storage resilience targets
SECTION XII — QUALITY AND VALIDATION FRAMEWORK
Validation Domain | Requirement |
Identity Validation | Marker concordance across RNA and protein |
Functional Validation | Assay-confirmed cellular behavior |
Lineage Validation | Trajectory consistency |
EV Validation | Cargo and recipient-cell confirmation |
Reproducibility | Cross-donor and cross-cohort consistency |
Translational Readiness | Fit for biomarker or engineering use |
SECTION XIII — SINGLE-CELL MULTI-OMIC MAPPING INDEX
Single-Cell Resolution Index (SCRI)
Domain | Score |
Cell Identity Resolution | 0–20 |
Functional State Resolution | 0–20 |
Lineage Trajectory Resolution | 0–20 |
EV Communication Resolution | 0–20 |
Engineering Target Resolution | 0–20 |
Total Score:
0–100
Score | Interpretation |
80–100 | Complete high-resolution mapping |
60–79 | Strong translational map |
40–59 | Partial discovery-grade map |
20–39 | Low-resolution characterization |
<20 | Insufficient mapping |
SECTION XIV — TRANSLATIONAL DEVELOPMENT ROADMAP
CHAR-H1 — Reference Atlas Construction
Develop healthy donor single-cell reference maps.
CHAR-H2 — Disease-State Mapping
Profile disease cohorts and identify cellular drift signatures.
CHAR-H3 — EVomic Integration
Link cell states to EV production, cargo, and address codes.
CHAR-H4 — Engineering Target Discovery
Prioritize targets for diagnostics, therapeutics, and synthetic blood systems.
CHAR-H5 — Digital Twin Integration
Integrate single-cell maps into the Blood Digital Twin Platform.
CHAR-H6 — Clinical Translation
Convert validated signatures into assays, biomarkers, and therapeutic engineering programs.
NEXT DELIVERABLE
HEMOREGEN-CHAR-003 — Universal EVomic Characterization Atlas